miRecule, Inc.
PrivateLast Round
Series A
Jul 14, 2024
Total Funding Raised
$38.56M
Company Overview
miRecule, Inc. operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a Strategic round in October 2022.
miRecule, Inc. is a biotechnology company developing RNA-based therapies for cancer and muscular dystrophy using its proprietary DREAmiR platform to create highly tailored therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
miRecule, Inc. Comparables
Compare miRecule, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avidity Biosciences | 80% | |
| Epicrispr Biotechnologies | 79% | |
| Novartis | 79% |
For institutional investors. Book with your work email.
miRecule, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2024 | ||||
| Strategic | Oct 4, 2022 | ||||
| Grant | Sep 29, 2022 | ||||
| Grant | Feb 28, 2022 | ||||
| Grant | May 27, 2021 | ||||
Seed | May 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
miRecule, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Boutique Venture Partners | Seed |
| Solve FSHD | Grant |
| Alexandria Venture Investments | Seed |
| Pathway Bioventures | Seed |
| FSHD Society | Seed |
| University System of Maryland Momentum Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2024
Completed a Series A funding round.
- Feb 28, 2022
Secured $100K in grant funding.
For institutional investors. Book with your work email.
miRecule, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about miRecule, Inc.'s valuation, stock price, and market status.
Is miRecule, Inc. a public or private company?
miRecule, Inc. is a private company.
What is the current stock price of miRecule, Inc.?
miRecule, Inc. is a private company, so its shares have no public market price. Caplight tracks miRecule, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is miRecule, Inc. worth (valuation)?
Valuation information for miRecule, Inc. is not publicly available.
Can I buy miRecule, Inc. stock?
miRecule, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was miRecule, Inc.'s last funding round?
miRecule, Inc.'s most recent funding round was Series A on July 14, 2024.
Who are the main investors in miRecule, Inc.?
Key investors in miRecule, Inc. include Solve FSHD, Alexandria Venture Investments.
Will miRecule, Inc. IPO soon?
No public IPO plans have been announced for miRecule, Inc..
How can I track miRecule, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in miRecule, Inc.'s shares on secondary markets.